ArticleFrontiers in pharmacology2026

Cyclovirobuxine D suppresses cancer stemness in osteosarcoma with implication of the noncanonical NF-kappaB pathway.

Jinku Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.